Hiromi Kazuno
Hanno Research Center
Taiho Pharmaceutical Co.
Ltd., Hanno-city
Saitama 357-8527
Japan
Name/email consistency: high
- 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo. Kazuno, H., Fujioka, A., Fukushima, M., Wataya, Y., Matsuda, A., Sasaki, T. Int. J. Oncol. (2009)
- Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil. Kazuno, H., Shimamoto, Y., Tsujimoto, H., Fukushima, M., Matsuda, A., Sasaki, T. Oncol. Rep. (2007)
- Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line. Kazuno, H., Sakamoto, K., Fujioka, A., Fukushima, M., Matsuda, A., Sasaki, T. Cancer Sci. (2005)